{
    "clinical_study": {
        "@rank": "134341", 
        "arm_group": [
            {
                "arm_group_label": "Arm A", 
                "arm_group_type": "Experimental", 
                "description": "Lenalidomide 10 mg/day for 21 days every 28 days for 4 courses.\nEvaluation of response at the end of 4 months according to IWG 2006 and IWG 2000 criteria.\nMaintenance: responders will continue to follow the corresponding treatment arm until relapse occurs; non responders at cycle 4 in arm A will be considered in failure of treatment and the introduction of Epoetin beta is at the discretion of the physician.\nThe patients will be followed every 3 months for 12 months"
            }, 
            {
                "arm_group_label": "Arm B", 
                "arm_group_type": "Experimental", 
                "description": "Lenalidomide 10 mg/day for 21 days every 28 days for 4 courses combined with weekly subcutaneous injections of Epoetin beta (60,000 Units/w).\nEvaluation of response at the end of 4 months according to IWG 2006 and IWG 2000 criteria.\nMaintenance: responders will continue to follow the corresponding treatment arm until relapse occurs; non responders at cycle 4 in arm A will be considered in failure of treatment and the introduction of Epoetin beta is at the discretion of the physician.\nThe patients will be followed every 3 months for 12 months"
            }
        ], 
        "brief_summary": {
            "textblock": "The goal of the present study is to assess, through a randomized phase II trial, the\n      efficacy and safety of Lenalidomide with or without Epoetin beta in transfusion-dependent,\n      ESA-resistant, IPSS low and intermediate-1 risk MDS patients without chromosome 5\n      abnormality.\n\n      Patients will receive either Lenalidomide alone or Lenalidomide and Epoetin beta for 4\n      months. Responders will be eligible for maintenance treatment with cycles identical to the\n      first cycles, until relapse occurs or until unacceptable toxicity."
        }, 
        "brief_title": "Lenalidomide in Subject With Low and Intermediate-1 Risk MDS and Without Chromosome 5 Abnormality.", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Myelodysplastic Syndromes", 
        "condition_browse": {
            "mesh_term": [
                "Congenital Abnormalities", 
                "Myelodysplastic Syndromes", 
                "Preleukemia"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a multi-center, open-label, randomized, Phase II study.\n\n      Patients will be treated either with arm A or B\n\n        -  Arm A: Lenalidomide 10 mg/day for 21 days every 28 days for 4 courses.\n\n        -  Arm B: Lenalidomide 10 mg/day for 21 days every 28 days for 4 courses combined with\n           weekly subcutaneous injections of Epoetin beta (60,000 Units/w).\n\n      Evaluation of response at the end of 4 months according to IWG 2006 and IWG 2000 criteria.\n\n      Maintenance: responders will continue to follow the corresponding treatment arm until\n      relapse occurs; non responders at Evaluation of response at the end of 4 months according to\n      IWG 2006 and IWG 2000 criteria.\n\n      in arm A will be considered in failure of treatment and the introduction of Epoetin beta is\n      at the discretion of the physician.\n\n      The patients will be followed every 3 months for 12 months"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        MDS defined as\n\n          -  Low or int-1 IPSS score\n\n          -  Documented absence of chromosome 5 abnormality (del(5q) or -5 karyotype)\n\n          -  De novo MDS, excluding therapy-related MDS AND\n\n          -  Transfusion dependance (requirement of at least 4 units of RBC transfusions every 8\n             weeks )\n\n          -  Resistance or loss of response to a previous treatment with Epoetin alpha/beta (at\n             least 60,000 Units/w) or Darbepoetin (at least 250 \u00b5g/w), for at least 12 weeks\n\n          -  Ineligibility for allogeneic stem cell transplantation or intensive chemotherapy\n             during the next 12 months\n\n          -  ECOG performance status \u2264 2\n\n          -  Age \u2265 18 years\n\n          -  Life expectancy \u2265 3 months\n\n          -  Adequate liver function (transaminases serum levels \u2264 3N)\n\n          -  Adequate renal function (calculate creatinine clearance > 50 ml/min)\n\n          -  Female subjects of chilbearing potential* must :\n\n        Agree to use effective contraception without interruption throughout    the study and for\n        at least 4 weeks after the end of treatment\n\n        \u2022 Men must: Agree to not conceive during the treatment and to use effective contraception\n        during the treatment period (including periods of dose reduction or temporary suspension)\n        and during one week after end of treatment if their partner is of childbearing potential.\n\n        Exclusion Criteria:\n\n          -  Active serious infection not controlled by oral or intravenous antibiotics\n\n          -  Platelets less than 50 G/L\n\n          -  Prior history of deep vein thrombosis or pulmonary embolism\n\n          -  Previous treatment by Thalidomide\n\n          -  Treatment with any investigational antileukemic agent or chemotherapy at least 6\n             weeks prior to study entry and lack of full recovery from side effects due to prior\n             therapy independent of when that therapy were given\n\n          -  Rapidely progressive disease with copromised organ function judged to be\n             life-threatening by the Investigator\n\n          -  Pregnant or lactating female\n\n          -  Known human immunodeficiency virus (HIV) infection\n\n          -  Known active hepatitis B and/or C virus infection\n\n          -  Hypersensitivity or intolerance to Lenalidomide or any of the excipients\n\n          -  Hypersensitivity to Epoetin beta or any of the excipients\n\n          -  Uncontrolled arterial hypertension\n\n          -  Any history of malignancy (other than myelodysplastic syndrome) unless the patient\n             has remained disease free for more than 5 years"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "132", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01718379", 
            "org_study_id": "GFM-Len-Epo-08"
        }, 
        "intervention": [
            {
                "arm_group_label": "Arm A", 
                "description": "Lenalidomide:10 mg per day during 21 days", 
                "intervention_name": "Lenalidomide", 
                "intervention_type": "Drug", 
                "other_name": "Revlimid"
            }, 
            {
                "arm_group_label": "Arm B", 
                "description": "Epoetin beta: 60,000 Units/week.", 
                "intervention_name": "Epoetin beta", 
                "intervention_type": "Drug", 
                "other_name": "NEORECORMON"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Epoetin Alfa", 
                "Lenalidomide", 
                "Thalidomide"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Myelodysplasia", 
        "lastchanged_date": "March 19, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "CHU Albert Michallon", 
                        "country": "France", 
                        "state": "Grenoble", 
                        "zip": "38043"
                    }, 
                    "name": "Hematology Dpt, Service d'H\u00e9matologie Clinique"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Le Kremlin-Bic\u00eatre", 
                        "country": "France", 
                        "state": "Ile de France", 
                        "zip": "94275"
                    }, 
                    "name": "Hematology Dpt, CHU de Bic\u00eatre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "state": "Ile de France", 
                        "zip": "75679"
                    }, 
                    "name": "Hematology Dpt, CHU Cochin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amiens", 
                        "country": "France", 
                        "zip": "80054"
                    }, 
                    "name": "Chu Amiens"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Angers", 
                        "country": "France", 
                        "zip": "43033"
                    }, 
                    "name": "CHU Angers"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Avignon", 
                        "country": "France", 
                        "zip": "84000"
                    }, 
                    "name": "Hematology Dpt, CH d'Avignon-305 rue Follereau-"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bayonne", 
                        "country": "France", 
                        "zip": "64 100"
                    }, 
                    "name": "CH de la Cote Basque"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Blois", 
                        "country": "France", 
                        "zip": "41016"
                    }, 
                    "name": "centre de Blois"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bobigny", 
                        "country": "France", 
                        "zip": "93009"
                    }, 
                    "name": "Hopital Avicenne"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France", 
                        "zip": "33604"
                    }, 
                    "name": "Hematology Dpt, CHU Haut-L\u00e9v\u00e8que"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boulogne Sur Mer", 
                        "country": "France", 
                        "zip": "62321"
                    }, 
                    "name": "H\u00f4pital Boulogne Sur Mer"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brest", 
                        "country": "France", 
                        "zip": "29609"
                    }, 
                    "name": "h\u00f4pital Morvan"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Caen", 
                        "country": "France", 
                        "zip": "14033"
                    }, 
                    "name": "CHU Cl\u00e9menceau"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Carcassonne", 
                        "country": "France", 
                        "zip": "11890"
                    }, 
                    "name": "CH de Carcassonne"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cergy-pontoise", 
                        "country": "France", 
                        "zip": "95303"
                    }, 
                    "name": "Hematology Dpt, CH Ren\u00e9 Dubos"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clermont-Ferrand", 
                        "country": "France", 
                        "zip": "63058"
                    }, 
                    "name": "CHU de Clermont-Ferrand"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Compi\u00e8gne", 
                        "country": "France", 
                        "zip": "60321"
                    }, 
                    "name": "CH de Compi\u00e8gne"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Corbeil-essonnes", 
                        "country": "France", 
                        "zip": "91100"
                    }, 
                    "name": "Hematology Dpt, H\u00f4pital Sud Francilien"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cr\u00e9teil", 
                        "country": "France", 
                        "zip": "94010"
                    }, 
                    "name": "hopital Henri Mondor"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dijon", 
                        "country": "France", 
                        "zip": "21034"
                    }, 
                    "name": "CHU de Dijon"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Le Chesnay", 
                        "country": "France", 
                        "zip": "78157"
                    }, 
                    "name": "Hematology Dpt, H\u00f4pital Versailles"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Le mans", 
                        "country": "France", 
                        "zip": "72037"
                    }, 
                    "name": "Hematology Dpt,CH Le mans"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France", 
                        "zip": "59160"
                    }, 
                    "name": "Hopital Saint-Vincent de Paul"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France", 
                        "zip": "59037"
                    }, 
                    "name": "CHRU Huriez"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Limoges", 
                        "country": "France", 
                        "zip": "87046"
                    }, 
                    "name": "CHRU de Limoges"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69495"
                    }, 
                    "name": "Hematology Dpt, Centre Hospitalier Lyon Sud"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mantes-la-jolie", 
                        "country": "France", 
                        "zip": "78201"
                    }, 
                    "name": "CH de Mantes-la-jolie"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13009"
                    }, 
                    "name": "Institut Paoli Calmettes"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nancy", 
                        "country": "France", 
                        "zip": "54511"
                    }, 
                    "name": "Hematology Dpt, CHU Brabois"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France", 
                        "zip": "44093"
                    }, 
                    "name": "Hematology Dpt, CHU de nantes"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France", 
                        "zip": "06202"
                    }, 
                    "name": "Hematology Dpt, CHU Archet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nimes", 
                        "country": "France", 
                        "zip": "30029"
                    }, 
                    "name": "Hematology Dpt, CHU Caremeau"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orl\u00e9ans", 
                        "country": "France", 
                        "zip": "45067"
                    }, 
                    "name": "Hematology Dpt, CHR La Source orl\u00e9ans"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75475"
                    }, 
                    "name": "Hematology Dpt, Hopital Saint Louis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75571"
                    }, 
                    "name": "Hopital Saint Antoine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75013"
                    }, 
                    "name": "Hematology Dpt, H\u00f4pital la piti\u00e9-Salp\u00e9tri\u00e8re"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris Saint Cloud", 
                        "country": "France", 
                        "zip": "92210"
                    }, 
                    "name": "centre Ren\u00e9 Huguenin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Perpignan", 
                        "country": "France", 
                        "zip": "66046"
                    }, 
                    "name": "Hematology Dpt, H\u00f4pital Mar\u00e9chal Joffre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Poitiers", 
                        "country": "France", 
                        "zip": "86021"
                    }, 
                    "name": "H\u00f4pital Jean Bernard"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pringy cedex", 
                        "country": "France", 
                        "zip": "74374"
                    }, 
                    "name": "Hematology Dpt, Centre Hospitalier de la r\u00e9gion d'Annecy"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Reims", 
                        "country": "France", 
                        "zip": "51092"
                    }, 
                    "name": "CHRU de Reims"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rennes", 
                        "country": "France", 
                        "zip": "35033"
                    }, 
                    "name": "CHU Pontchaillou"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rouen", 
                        "country": "France", 
                        "zip": "76038"
                    }, 
                    "name": "Centre Henri Becquerel"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sint Quentin", 
                        "country": "France", 
                        "zip": "02321"
                    }, 
                    "name": "CH de Saint Quentin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Strasbourg", 
                        "country": "France", 
                        "zip": "67098"
                    }, 
                    "name": "Chu Strasbourg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "zip": "31059"
                    }, 
                    "name": "Hematology Dpt, CHU PURPAN"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tours", 
                        "country": "France", 
                        "zip": "37044"
                    }, 
                    "name": "Hematology Dpt, CH CHU Bretoneau"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Monaco", 
                        "country": "Monaco", 
                        "zip": "98012"
                    }, 
                    "name": "centre hopitalier princesse Grace"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "Monaco"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase II Study Evaluating the Efficacy/Safety of Lenalidomide With or Without Epoetin Beta in Transfusion-dependent ESA-resistant Patients With IPSS Low- and Intermediate-1 Risk Myelodysplastic Syndromes Without Chromosome 5 Abnormality.", 
        "overall_official": [
            {
                "affiliation": "Groupe Francophone des Myelodysplasies", 
                "last_name": "Andr\u00e9a TOMA, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Groupe Francophone des Myelodysplasies", 
                "last_name": "Fran\u00e7ois Dreyfus, MD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "France: ANSM agence nationale de s\u00e9cuit\u00e9 du m\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Primary outcome is a complete or partial response defined by the IWG 2006 criteria observed after 4 months of treatment. Comparison in the rate of response between the two groups will be performed with Chi-square test or if necessary Fisher exact test.\nSame analyzes will be performed with the IWG 2000 response definition .", 
            "measure": "Comparing the efficacy of Lenalidomide alone to Lenalidomide with Epoetin beta in transfusion-dependent ESA-resistant", 
            "safety_issue": "Yes", 
            "time_frame": "After 4 months of treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01718379"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Safety of Lenalidomide and of its combination with Epoetin beta: adverse events (type, frequency, severity) and relationship of adverse events to study drug\n% of major HI-E and minor HI-E after 4 courses according to IWG 2000 criteria\nErythroid response duration\nTime to response\nTime to progression according to IPSS\nRBC transfusion independence\nPrognostic factors of response\nSurvival\nQuality of life", 
            "measure": "will be to assess the safety of Lenalidomide and of its combination with Epoetin beta", 
            "safety_issue": "Yes", 
            "time_frame": "After 2 months of treatment"
        }, 
        "source": "Groupe Francophone des Myelodysplasies", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Celgene Corporation", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "Roche Pharma AG", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "Groupe Francophone des Myelodysplasies", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}